Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-26

FDA Approved: FENOPRON TM — Supplemental Application (Galt Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves a supplemental application for Fenoprofen calcium (FENOPRON TM) by Galt Pharmaceuticals, LLC, to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOPRON TM (Fenoprofen calcium)

Snippet

SUPPL AP for FENOPRON TM (FENOPROFEN CALCIUM)